Matches in SemOpenAlex for { <https://semopenalex.org/work/W2314413450> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2314413450 endingPage "13" @default.
- W2314413450 startingPage "1" @default.
- W2314413450 abstract "Owing to the poor prognosis of patients with ovarian cancer, new treatment strategies immediately need to be developed. Although several immunotherapeutic approaches have been examined for the treatment of advanced stage ovarian cancer, their implementation in clinical practice remains low. We previously showed doxorubicin-treated murine ovarian cancer cells [murine ovarian surface epithelial cells (MOSECs)] are able to deliver drug to adjacent cells in vivo to eradicate tumor cells. In this study, we hypothesized that irradiated tumor cell treated with anticancer drugs may kill other cancer cell by cell to cell contact and also by generating antitumor immune responses. The MOSECs treated with anticancer drugs (doxorubicin and cisplatin) died through apoptosis, and this was increased in accordance with the dose of drug. The cleaved caspase-3 expression was significantly increased in the MOSECs coexposed with doxorubicin and cisplatin. Anticancer drug-treated MOSECs generated MOSEC-specific CD4+ T-cell immune responses. Bone marrow-derived dendritic cells expressed upregulated IL-12p40 mRNA but IL-6 and IL-10 mRNA downregulated after coculture with MOSECs cotreated with doxorubicin and cisplatin. Furthermore, the mice vaccinated with MOSECs cotreated with doxorubicin and cisplatin had enhanced antitumor immunity and prolonged survival. We also observed that CD4+ T cells and natural killer cells are essential for the antitumor immunity generated by vaccination with anticancer drug-loaded MOSECs. These findings suggest that irradiated MOSECs treated with anticancer drugs could be a new immune-therapeutic strategy against advanced ovarian cancers." @default.
- W2314413450 created "2016-06-24" @default.
- W2314413450 creator A5009881968 @default.
- W2314413450 creator A5030782922 @default.
- W2314413450 creator A5056285417 @default.
- W2314413450 creator A5062200350 @default.
- W2314413450 creator A5062803843 @default.
- W2314413450 creator A5065006809 @default.
- W2314413450 creator A5080493382 @default.
- W2314413450 date "2012-01-01" @default.
- W2314413450 modified "2023-10-17" @default.
- W2314413450 title "Cancer Cells Containing Nanoscale Chemotherapeutic Drugs Generate Antiovarian Cancer-specific CD4+ T Cells in Peritoneal Space" @default.
- W2314413450 doi "https://doi.org/10.1097/cji.0b013e3182328569" @default.
- W2314413450 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22130157" @default.
- W2314413450 hasPublicationYear "2012" @default.
- W2314413450 type Work @default.
- W2314413450 sameAs 2314413450 @default.
- W2314413450 citedByCount "10" @default.
- W2314413450 countsByYear W23144134502013 @default.
- W2314413450 countsByYear W23144134502014 @default.
- W2314413450 countsByYear W23144134502017 @default.
- W2314413450 countsByYear W23144134502018 @default.
- W2314413450 countsByYear W23144134502020 @default.
- W2314413450 countsByYear W23144134502022 @default.
- W2314413450 crossrefType "journal-article" @default.
- W2314413450 hasAuthorship W2314413450A5009881968 @default.
- W2314413450 hasAuthorship W2314413450A5030782922 @default.
- W2314413450 hasAuthorship W2314413450A5056285417 @default.
- W2314413450 hasAuthorship W2314413450A5062200350 @default.
- W2314413450 hasAuthorship W2314413450A5062803843 @default.
- W2314413450 hasAuthorship W2314413450A5065006809 @default.
- W2314413450 hasAuthorship W2314413450A5080493382 @default.
- W2314413450 hasConcept C121608353 @default.
- W2314413450 hasConcept C126322002 @default.
- W2314413450 hasConcept C203014093 @default.
- W2314413450 hasConcept C2776694085 @default.
- W2314413450 hasConcept C2778239845 @default.
- W2314413450 hasConcept C2780427987 @default.
- W2314413450 hasConcept C2781303535 @default.
- W2314413450 hasConcept C502942594 @default.
- W2314413450 hasConcept C71924100 @default.
- W2314413450 hasConcept C8891405 @default.
- W2314413450 hasConcept C96232424 @default.
- W2314413450 hasConcept C98274493 @default.
- W2314413450 hasConceptScore W2314413450C121608353 @default.
- W2314413450 hasConceptScore W2314413450C126322002 @default.
- W2314413450 hasConceptScore W2314413450C203014093 @default.
- W2314413450 hasConceptScore W2314413450C2776694085 @default.
- W2314413450 hasConceptScore W2314413450C2778239845 @default.
- W2314413450 hasConceptScore W2314413450C2780427987 @default.
- W2314413450 hasConceptScore W2314413450C2781303535 @default.
- W2314413450 hasConceptScore W2314413450C502942594 @default.
- W2314413450 hasConceptScore W2314413450C71924100 @default.
- W2314413450 hasConceptScore W2314413450C8891405 @default.
- W2314413450 hasConceptScore W2314413450C96232424 @default.
- W2314413450 hasConceptScore W2314413450C98274493 @default.
- W2314413450 hasIssue "1" @default.
- W2314413450 hasLocation W23144134501 @default.
- W2314413450 hasLocation W23144134502 @default.
- W2314413450 hasOpenAccess W2314413450 @default.
- W2314413450 hasPrimaryLocation W23144134501 @default.
- W2314413450 hasRelatedWork W1971929983 @default.
- W2314413450 hasRelatedWork W2053306150 @default.
- W2314413450 hasRelatedWork W2091461259 @default.
- W2314413450 hasRelatedWork W2149068418 @default.
- W2314413450 hasRelatedWork W2374053201 @default.
- W2314413450 hasRelatedWork W2406596433 @default.
- W2314413450 hasRelatedWork W2406608798 @default.
- W2314413450 hasRelatedWork W2460036924 @default.
- W2314413450 hasRelatedWork W3120025342 @default.
- W2314413450 hasRelatedWork W4385496679 @default.
- W2314413450 hasVolume "35" @default.
- W2314413450 isParatext "false" @default.
- W2314413450 isRetracted "false" @default.
- W2314413450 magId "2314413450" @default.
- W2314413450 workType "article" @default.